{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:18:36Z","timestamp":1756995516653,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-023-02826-w","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T10:03:22Z","timestamp":1678874602000},"page":"1143-1155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of Fabry Disease in patients with left ventricular hypertrophy in Turkey: Multicenter study (LVH-TR subgroup analysis)"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7925-2398","authenticated-orcid":false,"given":"Tuncay","family":"G\u00fczel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-2972","authenticated-orcid":false,"given":"Fatma Nihan Turhan","family":"\u00c7a\u011flar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0775-8992","authenticated-orcid":false,"given":"Berkay","family":"Ekici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0867-3264","authenticated-orcid":false,"given":"Mehmet","family":"K\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0268-9641","authenticated-orcid":false,"given":"Selvi","family":"\u00d6zta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0205-1138","authenticated-orcid":false,"given":"Ahmet","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1866-3753","authenticated-orcid":false,"given":"G\u00fclay","family":"G\u00f6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-4324","authenticated-orcid":false,"given":"Zeynep","family":"Kolak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4293-0017","authenticated-orcid":false,"given":"Ercan","family":"Ak\u015fit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9741-1196","authenticated-orcid":false,"given":"S\u00fcleyman An\u0131l","family":"Sar\u0131ca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0667-2516","authenticated-orcid":false,"given":"Murat","family":"Bayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4834-5572","authenticated-orcid":false,"given":"O\u011fuzhan","family":"Birdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1078-9095","authenticated-orcid":false,"given":"Berat","family":"U\u011fuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-313X","authenticated-orcid":false,"given":"Mesut","family":"Gitmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-1212","authenticated-orcid":false,"given":"G\u00fcl \u0130layda","family":"Berk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-4589","authenticated-orcid":false,"given":"Mustafa","family":"O\u011fuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-3747","authenticated-orcid":false,"given":"Ali Nazmi","family":"\u00c7al\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-2675","authenticated-orcid":false,"given":"Salih","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-4063","authenticated-orcid":false,"given":"Mehdi","family":"Zoghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"As\u0131m Oktay","family":"Ergene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"2826_CR1","first-page":"139","volume":"105","author":"P Ana Baptista","year":"2015","unstructured":"Ana Baptista P, Magalh\u00e3es S (2015) Screening for Fabry Disease in Left ventricular hypertrophy: documentation of a Novel mutation. Arq Bras Cardiol 105:139\u2013144","journal-title":"Arq Bras Cardiol"},{"key":"2826_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1185\/03007995.2012.754348","volume":"29","author":"T Coelho","year":"2013","unstructured":"Coelho T, Maurer MS, Suhr OB (2013) THAOS-The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin 29:63\u201376","journal-title":"Curr Med Res Opin"},{"key":"2826_CR3","first-page":"139","volume":"105","author":"A Baptista","year":"2015","unstructured":"Baptista A, Magalh\u00e3es P, Le\u00e3o S et al (2015) Screening for fabry disease in left ventricular hypertrophy: documentation of a novel mutation. Arq Bras Cardiol 105:139\u2013144","journal-title":"Arq Bras Cardiol"},{"key":"2826_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cjca.2017.04.015","volume":"33","author":"H Yogasundaram","year":"2017","unstructured":"Yogasundaram H, Kim D, Oudit O et al (2017) Clinical features, diagnosis,and management of patients with Anderson-Fabry Cardiomyopathy. Can J Cardiol 33:883\u2013897","journal-title":"Can J Cardiol"},{"key":"2826_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10741-014-9452-9","volume":"20","author":"BN Putko","year":"2015","unstructured":"Putko BN, Wen K, Thompson RB et al (2015) Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment. Heart Fail Rev 20:179\u2013191","journal-title":"Heart Fail Rev"},{"issue":"9","key":"2826_CR6","doi-asserted-by":"publisher","first-page":"e0239675","DOI":"10.1371\/journal.pone.0239675","volume":"28","author":"C Sadasivan","year":"2020","unstructured":"Sadasivan C, Chow JTY, Sheng B et al (2020) Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy. PLoS ONE 28(9):e0239675","journal-title":"PLoS ONE"},{"key":"2826_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1510198","volume":"375","author":"DP Germain","year":"2016","unstructured":"Germain DP, Hughes DA, Nicholls K et al (2016) Treatment of Fabry\u2019s Disease with the pharmacologic chaperone Migalastat. N Engl J Med 375:545\u2013555","journal-title":"N Engl J Med"},{"doi-asserted-by":"crossref","unstructured":"Cresci S, Pereira NL, Ahmad F et al (2019) Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association. Circulation: Genomic and Precision Medicine. ;12(10):e000058","key":"2826_CR8","DOI":"10.1161\/HCG.0000000000000058"},{"key":"2826_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10545-013-9659-2","volume":"37","author":"T Palecek","year":"2014","unstructured":"Palecek T, Honzikova J, Poupetova H et al (2014) Prevalence of fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective fabry cardiomyopathy screening study (FACSS). J Inherit Metab Dis 37:455\u2013460","journal-title":"J Inherit Metab Dis"},{"key":"2826_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1\u201339e14","journal-title":"J Am Soc Echocardiogr"},{"key":"2826_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.numecd.2020.08.028","volume":"31","author":"E Nardi","year":"2021","unstructured":"Nardi E, Mul\u00e8 G, Giammanco A et al (2021) Left ventricular hypertrophy in chronic kidney disease: a diagnostic criteria comparison. Nutr Metab Cardiovasc Dis 31:137\u2013144","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2826_CR12","first-page":"549","volume":"45","author":"M Kay\u0131k\u00e7\u0131o\u011flu","year":"2017","unstructured":"Kay\u0131k\u00e7\u0131o\u011flu M, \u015eim\u015fek E, Kalkan U\u00e7ar S et al (2017) Fabry disease: an overlooked diagnosis in adult cardiac patients. Turk Kardiyol Dern Ars 45:549\u2013555","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2826_CR13","doi-asserted-by":"publisher","first-page":"e006075","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","volume":"12","author":"MS Maurer","year":"2019","unstructured":"Maurer MS, Bokhari S, Damy T et al (2019) Expert Consensus Recommendations for the suspicion and diagnosis of Transthyretin Cardiac Amyloidosis. Circ Heart Fail 12:e006075","journal-title":"Circ Heart Fail"},{"key":"2826_CR14","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y et al (2021) Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 42:1554\u20131568","journal-title":"Eur Heart J"},{"key":"2826_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","volume":"103","author":"A Mehta","year":"2010","unstructured":"Mehta A, Beck M, Eyskens F et al (2010) Fabry disease: a review of current management strategies. QJM 103:641\u2013659","journal-title":"QJM"},{"key":"2826_CR16","first-page":"79","volume":"23","author":"HA Barman","year":"2020","unstructured":"Barman HA, \u00d6zcan S, At\u0131c\u0131 A et al (2020) Ratio of fabry disease in patients with idiopathic left ventricular hypertrophy: a single-center study in Turkey. Anatol J Cardiol 23:79\u201385","journal-title":"Anatol J Cardiol"},{"key":"2826_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10545-013-9659-2","volume":"37","author":"T Palecek","year":"2014","unstructured":"Palecek T, Honzikova J, Poupetova H, Vlaskova H, Kuchynka P, Golan L et al (2014) Prevalence of fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective fabry cardiomyopathy screening study (FACSS). J Inherit Metab Dis 37:455\u2013460","journal-title":"J Inherit Metab Dis"},{"key":"2826_CR18","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","volume":"366","author":"A Rolfs","year":"2005","unstructured":"Rolfs A, Bottcher T, Zschiesche M, Morris P, Winchester B, Bauer P et al (2005) Prevalence of fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 366:1794\u20131796","journal-title":"Lancet"},{"key":"2826_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30","journal-title":"Orphanet J Rare Dis"},{"key":"2826_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M et al (1995) An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N Engl J Med 333:288\u2013293","journal-title":"N Engl J Med"},{"key":"2826_CR21","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.ijcard.2012.06.069","volume":"167","author":"W Terryn","year":"2013","unstructured":"Terryn W, Deschoenmakere G, De Keyser J et al (2013) Prevalence of fabry disease in a predominantly hypertensive population with left ventricular hypertrophy. Int J Cardiol 167:2555\u20132560","journal-title":"Int J Cardiol"},{"doi-asserted-by":"publisher","unstructured":"Kis M, Dogan Y, Yildirim A, G\u00fczel T et al (2022 Oct) Evaluation of demographic, clinical, and aetiological data of patients admitted to cardiology clinics and diagnosed with left ventricular hypertrophy in turkish population (LVH-TR). Acta Cardiol 12:1\u201310. https:\/\/doi.org\/10.1080\/00015385.2022.2119670","key":"2826_CR22","DOI":"10.1080\/00015385.2022.2119670"},{"key":"2826_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jacc.2010.11.018","volume":"57","author":"MR Patel","year":"2011","unstructured":"Patel MR, Cecchi F, Cizmarik M et al (2011) Cardiovascular events in patients with fabry disease. J Am Coll Cardiol 57:1093\u20131099","journal-title":"J Am Coll Cardiol"},{"key":"2826_CR24","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/eurheartj\/ehs166","volume":"34","author":"Z Yousef","year":"2013","unstructured":"Yousef Z, Elliott PM, Cecchi F et al (2013) Left ventricular hypertrophy in fabry disease: a practical approach to diagnosis. Eur Heart J 34:802\u2013808","journal-title":"Eur Heart J"},{"key":"2826_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ultrasmedbio.2010.10.017","volume":"37","author":"M Niemann","year":"2011","unstructured":"Niemann M, Liu D, Hu K et al (2011) Prominent papillary muscles in fabry disease: a diagnostic marker? Ultrasound Med Biol 37:37\u201343","journal-title":"Ultrasound Med Biol"},{"key":"2826_CR26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/ejechocard\/jer112","volume":"12","author":"G Mundigler","year":"2011","unstructured":"Mundigler G, Gaggl M, Heinze G et al (2011) The endocardial binary appearance (\u2018binary sign\u2019) is an unreliable marker for echocardiographic detection of fabry disease in patients with left ventricular hypertrophy. Eur J Echocardiogr 12:744\u2013749","journal-title":"Eur J Echocardiogr"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-02826-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-023-02826-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-02826-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T03:44:01Z","timestamp":1685159041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-023-02826-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["2826"],"URL":"https:\/\/doi.org\/10.1007\/s10554-023-02826-w","relation":{},"ISSN":["1875-8312"],"issn-type":[{"type":"electronic","value":"1875-8312"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"assertion":[{"value":"24 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of ethics"}}]}}